CEF8, Influenza Virus NP (383-391)
Product Specifications
UNSPSC Description
CEF8, Influenza Virus NP (383-391), an influenza A virus nucleoprotein containing residues 383 to 391, is the most important HLA-B*2705-restricted epitope in the nucleoprotein of influenza A viruses and is associated with escape from cytotoxic T lymphocytes-mediated immunity[1][2].
Target Antigen
Influenza Virus
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cef8-influenza-virus-np-383-391.html
Solubility
10 mM in DMSO
Smiles
N=C(N)NCCC[C@@H](C(O)=O)NC([C@H]([C@H](O)C)NC([C@H](CCCNC(N)=N)NC([C@H]([C@@H](C)CC)NC([C@H](C)NC([C@H](CC1=CNC2=C1C=CC=C2)NC([C@H](CC3=CC=C(O)C=C3)NC([C@H](CCCNC(N)=N)NC([C@H](CO)N)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Weight
1208.40
References & Citations
[1]Berkhoff EG, et al. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol. 2004 May;78(10):5216-22.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P1835/CEF8-Influenza-Virus-NP-383-391-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P1835/
Clinical Information
No Development Reported
CAS Number
142479-13-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
